{
  "document": {
    "acknowledgments": [
      {
        "summary": "BD reported this vulnerability to NCCIC."
      }
    ],
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "summary",
        "text": "Successful exploitation of this vulnerability may allow an attacker to gain unauthorized access to administrative level privileges on a workstation, which could allow arbitrary execution of commands. This vulnerability does not impact BD FACSLyric flow cytometry systems using the Windows 7 Operating System.",
        "title": "Risk evaluation"
      },
      {
        "category": "other",
        "text": "CRITICAL INFRASTRUCTURE SECTORS: Healthcare and Public Health",
        "title": "Critical infrastructure sectors"
      },
      {
        "category": "other",
        "text": "COUNTRIES/AREAS DEPLOYED: Worldwide",
        "title": "Countries/areas deployed"
      },
      {
        "category": "other",
        "text": "COMPANY HEADQUARTERS LOCATION: United States",
        "title": "Company headquarters location"
      },
      {
        "category": "general",
        "text": "NCCIC recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "NCCIC reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.NCCIC also provides a section for control systems security recommended practices on the ICS-CERT web page. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS-CERT website in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to NCCIC for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-19-029-02 - Web Scraped Version",
        "url": "https://us-cert.cisa.gov/ics/advisories/ICSMA-19-029-02"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/advisories/"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B"
      }
    ],
    "title": "BD FACSLyric (Update A)",
    "tracking": {
      "current_release_date": "2022-10-10T21:50:49.796789+00:00",
      "generator": {
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSMA-19-029-02",
      "initial_release_date": "2019-02-05T00:00:00+00:00",
      "revision_history": [
        {
          "date": "2022-10-10T21:50:49.796789+00:00",
          "legacy_version": "Update A",
          "number": "1",
          "summary": "Publication Date"
        }
      ],
      "status": "final",
      "version": "1"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version",
                "name": "10  Professional Operating System U.S. release.",
                "product": {
                  "name": "FACSLyric - 10  Professional Operating System U.S. release.",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "FACSLyric"
          },
          {
            "branches": [
              {
                "category": "product_version",
                "name": "10  professional operating system u.s.  and  malaysian releases between november 2017 and  november 2018",
                "product": {
                  "name": "FACSLyric - 10  professional operating system u.s.  and  malaysian releases between november 2017 and  november 2018",
                  "product_id": "CSAFPID-0002"
                }
              }
            ],
            "category": "product_name",
            "name": "FACSLyric"
          }
        ],
        "category": "vendor",
        "name": "Becton, Dickinson and Company (BD)"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2019-6517",
      "cwe": {
        "id": "CWE-284",
        "name": "Improper Access Control"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The system does not properly enforce user access control to a privileged account, which may allow for unauthorized access to administrative level functions.CVE-2019-6517 has been assigned to this vulnerability. A CVSS v3 base score of 6.8 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2019-6517"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "BD will follow-up directly with all affected users to perform remediation activities. BD will disable the administrative account for users with BD FACSLyric RUO Cell Analyzer units having the Windows 10 Pro Operating System. BD has contacted and will replace the computer workstations for affected users with the BD FACSLyric IVD Cell Analyzer units with the Windows 10 Pro Operating System.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.cisa.gov/uscert/ics/advisories/"
        },
        {
          "category": "vendor_fix",
          "details": "For additional information regarding the reported vulnerability please contact BD for the following support:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.cisa.gov/uscert/ics/advisories/"
        },
        {
          "category": "vendor_fix",
          "details": "For technical support, please contact the BD Biosciences General Tech Support - Flow Cytometry via email researchapplications@bd.com or phone 877-232-8995 Option 2 and then Option 2 again.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.cisa.gov/uscert/ics/advisories/"
        },
        {
          "category": "vendor_fix",
          "details": "For more information on BD\u2019s product security and vulnerability management, contact BD\u2019s Product Security Office:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.cisa.gov/uscert/ics/advisories/"
        },
        {
          "category": "vendor_fix",
          "details": "https://www.bd.com/productsecurity \u00a0\u00a0 \u00a0",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.bd.com/productsecurity"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 6.8,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        }
      ]
    }
  ]
}